Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dannenberg, H.
Right arrow Articles by de Krijger, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dannenberg, H.
Right arrow Articles by de Krijger, R. R.
Clinical Cancer Research Vol. 8, 2061-2066, July 2002
© 2002 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Frequent Germ-Line Succinate Dehydrogenase Subunit D Gene Mutations in Patients with Apparently Sporadic Parasympathetic Paraganglioma

Hilde Dannenberg1, Winand N. M. Dinjens1,2, Mustaffa Abbou, Hero van Urk, Bernard K. H. Pauw, Diane Mouwen, Wolter J. Mooi and Ronald R. de Krijger

Department of Pathology, Josephine Nefkens Institute [H. D., W. N. M. D., M. A., R. R. d. K.] and Departments of Surgery [H. v. U., D. M.] and Otorhinolaryngology [B. K. H. P.], Erasmus Medical Center, 1738 Rotterdam, the Netherlands, and Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands [W. J. M.]

Purpose: Recently, familial paraganglioma (PGL) was shown to be caused bymutations in the gene encoding succinate dehydrogenase subunit D (SDHD). However, the prevalence of SDHD mutations in apparently sporadic PGL is unknown. We studied the frequency and spectrum of germ-line and somatic SDHD mutations in patients with parasympathetic PGL.

Experimental Design: We studied 57 unselected patients who developed parasympathetic PGLs (n = 105 tumors) and who were treated between 1987 and 1999 at the Erasmus MC (Rotterdam, the Netherlands). Thirty-eight (67%) of these patients (n = 51 tumors) lacked a family history of parasympathetic PGL. We used conformation-dependent gel electrophoresis and sequence determination analysis of germ-line and tumor DNA to identify SDHD mutations. We compared the clinical and molecular characteristics of sporadic and hereditary PGLs.

Results: Three different SDHD germ-line mutations were identified in 32 of the 57 (56%) patients. These included 19 of 19 (100%) patients with familial PGL and also 13 of 38 (34%) patients with apparently sporadic PGL. All three mutations were characterized as missense mutations (D92Y, L95P, and L139P) in highly conserved regions of the SDHD gene and were not observed in 200 control alleles. No somatic mutations were found.

Conclusions: Germ-line mutations of the SDHD gene are present in a significant number of patients with apparently sporadic parasympathetic PGL. Somatic SDHD mutations do not play a significant role in the sporadic form of this tumor. Genetic testing for SDHD germ-line mutations should be considered for every patient presenting with this tumor, even if a personal or family history of PGL is absent, to allow appropriate clinical management.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. Lima, T. Feijao, A. Ferreira da Silva, I. Pereira-Castro, G. Fernandez-Ballester, V. Maximo, A. Herrero, L. Serrano, M. Sobrinho-Simoes, and G. Garcia-Rostan
High Frequency of Germline Succinate Dehydrogenase Mutations in Sporadic Cervical Paragangliomas in Northern Spain: Mitochondrial Succinate Dehydrogenase Structure-Function Relationships and Clinical-Pathological Correlations
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4853 - 4864.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
L Simi, R Sestini, P Ferruzzi, M S Gagliano, F Gensini, M Mascalchi, L Guerrini, C Pratesi, P Pinzani, G Nesi, et al.
Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X
J. Med. Genet., August 1, 2005; 42(8): e52 - e52.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. Dannenberg, F. H. van Nederveen, M. Abbou, A. A. Verhofstad, P. Komminoth, R. R. de Krijger, and W. N.M. Dinjens
Clinical Characteristics of Pheochromocytoma Patients With Germline Mutations in SDHD
J. Clin. Oncol., March 20, 2005; 23(9): 1894 - 1901.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
B E Baysal, J E Willett-Brozick, P A A Filho, E C Lawrence, E N Myers, and R E Ferrell
An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma
J. Med. Genet., September 1, 2004; 41(9): 703 - 709.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
R F Badenhop, J C Jansen, P A Fagan, R S A Lord, Z G Wang, W J Foster, and P R Schofield
The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features
J. Med. Genet., July 1, 2004; 41(7): e99 - e99.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
A Cascon, S Ruiz-Llorente, M F Fraga, R Leton, D Telleria, J Sastre, J Jose Diez, G Martinez Diaz-Guerra, J A Diaz Perez, J Benitez, et al.
Genetic and epigenetic profile of sporadic pheochromocytomas
J. Med. Genet., March 1, 2004; 41(3): e30 - 30.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Lima, J. Teixeira-Gomes, P. Soares, V. Maximo, M. Honavar, D. Williams, and M. Sobrinho-Simoes
Germline Succinate Dehydrogenase Subunit D Mutation Segregating with Familial Non-RET C Cell Hyperplasia
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4932 - 4937.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Bryant, J. Farmer, L. J. Kessler, R. R. Townsend, and K. L. Nathanson
Pheochromocytoma: The Expanding Genetic Differential Diagnosis
J Natl Cancer Inst, August 20, 2003; 95(16): 1196 - 1204.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C Bauters, M-C Vantyghem, E Leteurtre, M-F Odou, C Mouton, N Porchet, J-L Wemeau, C Proye, and P Pigny
Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes
J. Med. Genet., June 1, 2003; 40(6): e75 - 75.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.